Φορτώνει......
Use of Productivity Loss/Gain in Cost-Effectiveness Analyses for Drugs: A Systematic Review
BACKGROUND: Inclusion of productivity losses and gains in cost-effectiveness analyses for drugs is recommended by pharmacoeconomic guidelines in some countries and is considered optional in others. Often guidelines recommend analysis based on the payer perspective, but suggest that a supplemental an...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Pharmacoeconomics |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer International Publishing
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7790765/ https://ncbi.nlm.nih.gov/pubmed/33230613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-020-00986-4 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|